News

DDL Unveils a New GMP Laboratory for Drug Testing Services

DDL Unveils a New GMP Laboratory for Drug Testing Services

DDL Launches Innovative GMP Laboratory for Enhanced Testing

DDL, a prominent provider of testing services for packages, products, and materials, has recently announced the establishment of a new Good Manufacturing Practice (GMP) laboratory focused on drug-device combination product testing. This significant addition strengthens DDL's role in the pharmaceutical and biotech sectors, providing reliable and regulatory-compliant testing solutions.

Overview of the New GMP Facility

The newly registered FDA GMP laboratory spans 10,600 square feet and is conveniently located near DDL's headquarters. This facility will offer essential services including ICH stability testing, mechanical performance evaluations, and simulated distribution testing. These services are crucial for the manufacturing of high-quality devices such as auto injectors, pre-filled syringes, inhalers, and other combination products. Equipped with cutting-edge technology and staffed by a team of seasoned engineers, DDL's facility is structured to deliver comprehensive testing solutions adhering to FDA, ISO, and global regulatory standards.

Expanding Testing Capabilities

"We are thrilled to expand our capabilities with this new GMP laboratory, which showcases our dedication to providing superior testing services to our medical device and pharmaceutical clients," stated Aaron Liss, Director of Sales & Marketing at DDL, Inc. This laboratory marks a pivotal opportunity for DDL to collaborate with new healthcare providers, leveraging the company’s 35 years of industry proficiency.

According to John Koch, General Manager of DDL, Inc., "The rising demand for combination products necessitates that manufacturers have access to ample expertise and resources. Our investment in this lab will play a key role in ensuring manufacturers can safely bring effective products to the market."

Commitment to Excellence in Testing Services

DDL's recent investment in this GMP laboratory represents a strategic initiative to reaffirm its commitment to excellence in lifecycle testing services for the life sciences sector. The laboratory will further facilitate DDL in delivering accurate, dependable, and regulatory-compliant results, which are essential for effective product development and regulatory submissions.

Engagement at INTERPHEX Conference

DDL is set to showcase its robust GMP testing capabilities along with its diverse offerings in package, medical device, and material testing at Booth #1143 during the INTERPHEX conference. This event will take place at the Javits Center, offering opportunities for industry professionals to connect and learn more about DDL's services.

For further details regarding DDL's testing solutions or to request a quote, prospective clients can reach DDL directly via email or by phone. Their commitment to quality assurance and innovative testing services continues to position DDL as a leader in the industry.

About DDL

DDL is a reputable independent testing entity that specializes in medical device, materials, and package testing, primarily aimed at servicing the life sciences industry. DDL operates testing laboratories strategically located in various regions, serving clients with every essential standard and regulatory requirement. For more information on the comprehensive range of testing services provided by DDL, please visit their official website.

Frequently Asked Questions

What is the primary focus of DDL's new GMP lab?

The GMP lab specializes in testing drug-device combination products to support the pharmaceutical and biotech industries.

Where is the new GMP laboratory located?

The laboratory is situated near DDL's headquarters, enhancing its operational efficiency and service availability.

What types of testing can DDL's GMP lab perform?

DDL's GMP lab offers ICH stability testing, mechanical performance testing, and simulated distribution testing among others.

How does DDL ensure compliance with regulatory standards?

DDL follows FDA, ISO, and global regulatory standards, ensuring that all testing services meet rigorous compliance requirements.

Where can I learn more about DDL's services?

For more information about DDL's extensive testing services, potential clients are encouraged to visit the official DDL website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading

Top 5 Most Recently Viewed Articles

Heartbreak from Tragic South Korea Plane Crash: A Father's Loss

Updated Category News Views 279

Unimaginable Loss Following Air Tragedy Jeon Je-young is grappling with a heartbreak that no parent should ever have to endure. The recent plane crash at an airport in South Korea, which claimed the lives of 179 people, has left him in disbelief and mourning. Among those who perished was his beloved daughter, Mi-sook. Her untimely death has turned a joyful holiday season...

Continue Reading
Vaxil Bio Ends Reverse Acquisition Plans with Green Data Centers

Updated Category News Views 174

Termination of Reverse Takeover Agreement Vaxil Bio Ltd. (“Vaxil” or the “Company”) (TSXV: VXL) has recently announced the termination of its definitive agreement with Green Data Center Real Estate Inc. This decision comes after careful consideration and mutual agreement between the two parties. Details of the Agreement Cancellation As stated in their...

Continue Reading
HBX Group Unveils Major Share Buy-Back and Dividend Plans

Updated Category News Views 167

HBX Group Announces Strategic Shareholder Returns HBX Group International plc, referred to as "HBX Group," is making headlines with an exciting commitment to its shareholders. The company is set to implement a substantial cash return strategy that includes a share buy-back program alongside the introduction of regular dividend payments. This move highlights the company's...

Continue Reading
Flux Power and Averest to Unveil Groundbreaking GSE Solutions

Updated Category News Views 115

Innovative Solutions for Ground Support with Flux Power Flux Power Holdings, Inc. (NASDAQ: FLUX), based in Vista, California, is making waves in the energy industry with its cutting-edge lithium-ion energy storage solutions. The company is dedicated to transforming airport ground support equipment (GSE), material handling, and a range of industrial applications through...

Continue Reading
Pentair's Inspiring Q3 Report: Strong Growth and Optimistic Outlook

Updated Category News Views 115

Pentair plc Reports Encouraging Q3 Results Pentair plc (NYSE: PNR) has recently announced its third-quarter financial performance for 2024, revealing a net sales figure of $993 million. This represents a slight decline of 2% year over year, yet it has outperformed analyst expectations, which were set at $988.8 million. Core Sales Insights The company's core sales...

Continue Reading